Silvercrest Asset Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Silvercrest Asset Management’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-16,666	Closed	-$227	–	886
2023 Q3	$227	Hold	16,666	–	–	﹤0.01%	829
2023 Q2	$3.05K	Hold	16,666	–	–	﹤0.01%	823
2023 Q1	$26.7K	Hold	16,666	–	–	﹤0.01%	789
2022 Q4	$33.2K	Sell	16,666 -333	-2%	-$821	﹤0.01%	783
2022 Q3	$59K	Hold	16,999	–	–	﹤0.01%	778
2022 Q2	$58K	Sell	16,999 -1	-0%	-$6	﹤0.01%	787
2022 Q1	$155K	Buy	+17,000	New	+$258K	﹤0.01%	818

Silvercrest Asset Management's SRGA Position: Q4 2023 in Review

Silvercrest Asset Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q4 2023, closing a stake of 16,666 shares — an estimated $227 sold.

Silvercrest Asset Management first reported a position in SRGA in Q1 2022 and held it in 7 quarters. The position peaked at $155K in Q1 2022. 0 funds tracked by Wall St. Rank hold SRGA as of Q4 2023.

Silvercrest Asset Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Silvercrest Asset Management sold 16,666 Surgalign Holdings, Inc. Common Stock shares in Q4 2023, an estimated $227.
Silvercrest Asset Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q1 2022 and held it in 7 quarters.
Silvercrest Asset Management's Surgalign Holdings, Inc. Common Stock position peaked at $155K in Q1 2022.
0 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q4 2023.

Based on Silvercrest Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.